Compare Intuitive Surgical, Inc. (ISRG) vs Boston Beer Company Inc (SAM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Intuitive Surgical, Inc. vs Boston Beer Company Inc — how do they compare? Intuitive Surgical, Inc. trades at $399.51 (market cap $141.75B), while Boston Beer Company Inc trades at $180.35 (market cap $1.86B). The key difference: Intuitive Surgical, Inc. is far larger — about 76.2× Boston Beer Company Inc's market cap. Which is the better fit depends on your goals.
| ISRG | SAM | |
|---|---|---|
Market Cap | $141.75B | $1.86B |
Sector | Health | Consumer Staples |
52-Week High | $592.85 | $260.05 |
52-Week Low | $332.02 | $161.08 |
Enterprise Value | $136.53B | $1.63B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Intuitive Surgical (ISRG) trades at $393.38, up 3.85% on the day, with a bullish technical signal and strong earnings momentum, having beaten EPS estimates for three consecutive quarters. The stock exhibits premium valuation metrics, including a P/E of 46.01 and P/S of 13.08, supported by robust revenue growth, which reached $10.06B in 2025, and high net income margins of 28.45%. Recent news highlights analyst upgrades and optimism around the da Vinci 5 system's adoption.
The outlook remains positive given durable demand and innovation, but risks include heightened competition and valuation sensitivity. Wall Street consensus is bullish with a $518.10 price target, implying significant upside, though investors should weigh premium multiples against growth sustainability and competitive pressures in the medtech space.
Boston Beer Company (SAM) trades at $181.95, up 0.53% with bearish technical signals despite recent earnings volatility. The stock shows mixed fundamentals with a P/E of 22.66 and P/S of 0.99, but faces profitability challenges with negative net income margin (-3.64%) and ROE (-8.61%). Recent Q2 2026 earnings missed estimates at $3.65 vs. $4.83 expected, while operating cash flow remains strong at $270M in 2025. Analyst sentiment is cautious with 72% hold ratings amid declining volumes and competitive pressures.
Outlook remains challenging with weak demand impacting core brands, though spirits-based RTD growth and margin improvements offer some support. The consensus price target of $207.33 suggests 14% upside potential, but investors face risks from sustained volume declines, rising marketing costs, and negative earnings growth projections for 2026. The stock's current technical position near pivot point resistance at $182 requires monitoring for breakout confirmation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Intuitive Surgical, Inc.
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.
Read more on ISRG →About Boston Beer Company Inc
Boston Beer is a leader in U.S. high-end malt beverages and adjacent categories, with strong positions in craft beer, hard cider, and hard seltzer. The firm sells an array of flavor variants and package sizes, predominantly centered around four priority brands: Samuel Adams, Angry Orchard, Twisted Tea, and Truly Hard Seltzer. Its drinks are produced in both company-owned breweries as well as through third-party contract arrangements, and while the company primarily goes to market through independent wholesalers (as mandated by law), it operates a fairly large salesforce to induce demand across the value chain (distributors, retailers, and drinkers). The preponderance of revenue is generated domestically.
Read more on SAM →
